Citigroup
GOCO

Citigroup’s GoHealth GOCO Stock Holding History

Citigroup’s Portfolio GOCO Stock Details GOCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-82,607
Closed -$4.7M – 6435
2021
Q4 		$4.7M Buy
+82,607
New +$5.51M ﹤0.01% 1884

Other funds holding GOCO

Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $19B AUM 51.73% 1-Year Est. Return
NEWAS
N.E.W. Advisory Services De Pere, Wisconsin $1.5B AUM 19.48% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 26.88% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citigroup's GOCO Position: Q2 2026 in Review

Citigroup sold out of GoHealth (GOCO) in Q2 2026, closing a stake of 438 shares — an estimated $661 sold.

Citigroup first reported a position in GOCO in Q3 2020 and held it in 19 quarters. The position peaked at $219K in Q2 2021. 5 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.

  • Citigroup reported no remaining GoHealth position as of Q2 2026 after selling out during the quarter.
  • Citigroup sold 438 GoHealth shares in Q2 2026, an estimated $661.
  • Citigroup first reported a position in GoHealth in Q3 2020 and held it in 19 quarters.
  • Citigroup's GoHealth position peaked at $219K in Q2 2021.
  • 5 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.